X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare ALEMBIC LTD with Piramal Healthcare - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC LTD vs PIRAMAL ENTERPRISES - Comparison Results

ALEMBIC LTD    Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

PIRAMAL ENTERPRISES 
   Change

Piramal Enterprises has a presence in custom manufacturing, critical care OTC and financial services. To give a boost to its custom manufacturing operations, the company had acquired Avecia Pharmaceuticals, UK in 2005 and Pfizer's Morpeth facility in... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC LTD PIRAMAL ENTERPRISES ALEMBIC LTD/
PIRAMAL ENTERPRISES
 
P/E (TTM) x 74.8 37.6 198.8% View Chart
P/BV x 2.8 3.7 74.1% View Chart
Dividend Yield % 0.4 0.6 62.3%  

Financials

 ALEMBIC LTD   PIRAMAL ENTERPRISES
EQUITY SHARE DATA
    ALEMBIC LTD
Mar-16
PIRAMAL ENTERPRISES
Mar-16
ALEMBIC LTD/
PIRAMAL ENTERPRISES
5-Yr Chart
Click to enlarge
High Rs531,065 5.0%   
Low Rs29805 3.6%   
Sales per share (Unadj.) Rs4.7383.0 1.2%  
Earnings per share (Unadj.) Rs8.855.1 15.9%  
Cash flow per share (Unadj.) Rs9.074.1 12.2%  
Dividends per share (Unadj.) Rs0.1517.50 0.9%  
Dividend yield (eoy) %0.41.9 19.5%  
Book value per share (Unadj.) Rs27.7719.9 3.9%  
Shares outstanding (eoy) m267.03172.56 154.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x8.72.4 356.3%   
Avg P/E ratio x4.717.0 27.6%  
P/CF ratio (eoy) x4.612.6 36.1%  
Price / Book Value ratio x1.51.3 114.0%  
Dividend payout %1.731.8 5.4%   
Avg Mkt Cap Rs m10,962161,344 6.8%   
No. of employees `000NA3.8 0.0%   
Total wages/salary Rs m23816,898 1.4%   
Avg. sales/employee Rs ThNM17,472.6-  
Avg. wages/employee Rs ThNM4,466.9-  
Avg. net profit/employee Rs ThNM2,512.8-  
INCOME DATA
Net Sales Rs m1,26066,099 1.9%  
Other income Rs m2642,425 10.9%   
Total revenues Rs m1,52468,524 2.2%   
Gross profit Rs m8318,723 0.4%  
Depreciation Rs m613,274 1.9%   
Interest Rs m09,388 0.0%   
Profit before tax Rs m2858,485 3.4%   
Minority Interest Rs m03 0.0%   
Prior Period Items Rs m2,0961,593 131.6%   
Extraordinary Inc (Exp) Rs m-32457 -7.1%   
Tax Rs m61,032 0.6%   
Profit after tax Rs m2,3439,506 24.6%  
Gross profit margin %6.628.3 23.2%  
Effective tax rate %2.112.2 17.6%   
Net profit margin %185.914.4 1,292.6%  
BALANCE SHEET DATA
Current assets Rs m1,68947,488 3.6%   
Current liabilities Rs m486104,362 0.5%   
Net working cap to sales %95.4-86.0 -110.9%  
Current ratio x3.50.5 763.3%  
Inventory Days Days21741 534.1%  
Debtors Days Days8151 158.4%  
Net fixed assets Rs m1,62426,532 6.1%   
Share capital Rs m534345 154.8%   
"Free" reserves Rs m5,960114,024 5.2%   
Net worth Rs m7,404124,221 6.0%   
Long term debt Rs m10475,812 0.1%   
Total assets Rs m8,010308,356 2.6%  
Interest coverage x950.71.9 49,933.8%   
Debt to equity ratio x00.6 2.3%  
Sales to assets ratio x0.20.2 73.4%   
Return on assets %29.36.1 477.4%  
Return on equity %31.67.7 413.5%  
Return on capital %31.310.0 314.1%  
Exports to sales %2.917.2 17.1%   
Imports to sales %28.96.6 437.1%   
Exports (fob) Rs m3711,362 0.3%   
Imports (cif) Rs m3644,364 8.3%   
Fx inflow Rs m3714,435 0.3%   
Fx outflow Rs m3655,183 7.0%   
Net fx Rs m-3289,253 -3.5%   
CASH FLOW
From Operations Rs m346-67,773 -0.5%  
From Investments Rs m-48-8,768 0.5%  
From Financial Activity Rs m-30176,199 -0.4%  
Net Cashflow Rs m-3-342 0.9%  

Share Holding

Indian Promoters % 64.0 52.9 121.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.2 4.0 5.0%  
FIIs % 9.7 26.6 36.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.1 16.5 158.2%  
Shareholders   54,701 93,274 58.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC LTD With:   ALKEM LABORATORIES  PLETHICO PHARMA  GLENMARK PHARMA  TORRENT PHARMA  BIOCON LTD  

Compare ALEMBIC LTD With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Weak Finish to the Week Post Vishal Sikka's Exit as CEO of Infosys(Closing)

Share markets in India witnessed selling pressure, led by slump in shares of Infosys Ltd. after Vishal Sikka resigned as chief executive officer of the country's second-largest software services exporter.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC LTD SHARE PRICE


Aug 18, 2017 (Close)

TRACK ALEMBIC LTD

  • Track your investment in ALEMBIC LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ALEMBIC LTD 5-YR ANALYSIS

COMPARE ALEMBIC LTD WITH

MARKET STATS